Mitsubishi Pharma competitive analysis

Latest publications and patents of Mitsubishi Pharma New

Explore the latest publications and patents granted to Mitsubishi Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Mitsubishi Pharma

Mar 28, 2018Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To AlsRevoked

Explore Mitsubishi Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 28, 2018Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als1

Latest PTAB cases involving Mitsubishi Pharma

Discover the latest PTAB cases involving Mitsubishi Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Mitsubishi Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MITSUBISHI PHARMA - 1 - - Non-Active
MAIWALD134 - - - Highly Aggressive